Alterations in expression of HIF-1α, HIF-2α, and VEGF by idiopathic overactive bladder urothelial cells during stretch suggest role for hypoxia

Urology

Volumn 77, Issue 5, 2011, Pages 1266.e7-1266.e11

  Christiaansen, Charlotte E ^a,b,c   Sun, Yan ^a,b,c   Hsu, Yu Chao ^a,b,c   Chai, Toby C ^a,b,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; VASCULOTROPIN;

ADULT; ARTICLE; BLADDER BIOPSY; BLADDER UROTHELIAL CELL; CELL CULTURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SUPERNATANT;

EID: 79955574270     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.12.041     Document Type: Article

References (23)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn. 2002;21:167-168.
2. Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87:760-766.
3. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327-336. (Pubitemid 44175300)
4. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306-1315.
5. Coyne KS, Payne C, Bhattacharyya SK, et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health. 2004;7:455-463. (Pubitemid 39038454)
6. Coyne KS, Zhou Z, Bhattacharyya SK, et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int. 2003;92:948-954. (Pubitemid 37548272)
7. Liberman JN, Hunt TL, Stewart WF, et al. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology. 2001;57:1044-1050. (Pubitemid 32455563)
8. Sun Y, Chai TC. Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol. 2004;171:448-452. (Pubitemid 37549209)
9. Azadzoi KM, Tarcan T, Kozlowski R, et al. Overactivity and structural changes in the chronically ischemic bladder. J Urol. 1999;162:1768-1778. (Pubitemid 29474727)
10. Brading A, Pessina F, Esposito L, et al. Effects of metabolic stress and ischaemia on the bladder, and the relationship with bladder overactivity. Scand J Urol Nephrol Suppl. 2004;215:84-92. (Pubitemid 39551374)
11. de Jong BW, Wolffenbuttel KP, Arentshorst ME, et al. Detrusor glycogen reflects the functional history of bladders with partial outlet obstruction. BJU Int. 2007;100:846-852. (Pubitemid 47360174)
12. de Jong BW, Wolffenbuttel KP, Scheepe JR, et al. The detrusor glycogen content of a de-obstructed bladder reflects the functional history of that bladder during PBOO. Neurourol Urodyn. 2008;27:454-460. (Pubitemid 351991213)
13. Azadzoi KM, Yalla SV, Siroky MB. Oxidative stress and neurodegeneration in the ischemic overactive bladder. J Urol. 2007;178:710-715. (Pubitemid 47030477)
14. Yang R, Amir J, Liu H, et al. Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis. Physiol Genomics. 2008;36:1-14.
15. Sun Y, Keay S, De Deyne PG, et al. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol. 2001;166:1951-1956. (Pubitemid 32953463)
16. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
17. Sun Y, Chai TC. Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol. 2004;171:448-452. (Pubitemid 37549209)
18. Watson JA, Watson CJ, McCrohan AM, et al. Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum Mol Genet. 2009;18:3594-3604.
19. Pagès G, Pouysségur J. Transcriptional regulation of the vascular endothelial growth factor gene - a concert of activating factors. Cardiovasc Res. 2005;65:564-573. (Pubitemid 40138977)
20. Jones A, Fujiyama C, Blanche C, et al. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Clin Cancer Res. 2001;7:1263-1272. (Pubitemid 32708679)
21. Saban R, Saban MR, Maier J, et al. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. Am J Physiol Ren Physiol. 2008;295:F1613-F1623.
22. Saban MR, Backer JM, Backer MV, et al. VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation. Am J Physiol Ren Physiol. 2008;295:F60-F72.
23. Tyagi P, Barclay D, Zamora R, et al. Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study. Int Urol Nephrol. 2009;42:629-635.